Lipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: rosuvastatin compared with other statins in usual care
Authors:
- Carolyn R HarleyCHCarolyn R Harley
- Sanjay K GandhiSGSanjay K Gandhi
- Herbert HeienHHHerbert Heien
- Ken McDonoughKMKen McDonough
- Stephanie P NelsonSNStephanie P Nelson
- 17 March 2008
- journal article
- research article
- Published by Informa Healthcare in Expert Opinion on Pharmacotherapy
- Vol. 9 (5) , 669-676
Abstract
Objective: To compare change in low-density lipoprotein cholesterol (LDL-C) levels and National Cholesterol Education Program (NCEP) Adult Treatment Panel III LDL-C goal attainment in diabetic patients treated with rosuvastatin versus other statins in a large, managed care health plan. Research Design and Methods: This retrospective cohort analysis used medical and pharmacy claims linked to laboratory results from a commercial/MedicareAdvantage health plan. Study participants were ≥ 18 years of age, had a diagnosis of diabetes, were newly treated with statins from 8/1/03 to 2/28/05, and were considered at high risk for cardiovascular events as defined by NCEP guidelines. Subjects were continuously enrolled for 12 months pre-index and ≥ 30 days post-index, with variable follow-up until therapy discontinuation or end of health plan eligibility. Main Outcome Measures: Change in LDL-C from baseline, and attainment of NCEP LDL-C goal among patients not at goal before starting therapy. Results: A total of 3337 ...Keywords
This publication has 30 references indexed in Scilit:
- Effects of Intense Low-Density Lipoprotein Cholesterol Reduction in Patients With Stroke or Transient Ischemic AttackStroke, 2007
- Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL‑C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United StatesCurrent Medical Research and Opinion, 2007
- Co‐administration of ezetimibe and simvastatin in acute myocardial infarctionEuropean Journal of Clinical Investigation, 2007
- Rosuvastatin in Elderly PatientsDrugs & Aging, 2007
- Treating to target patients with primary hyperlipidaemia:comparison of the effects of ATOrvastatin and ROSuvastatin (the ATOROS study)Current Medical Research and Opinion, 2006
- Patterns and Effectiveness of Lipid-Lowering Therapies in a Managed Care EnvironmentValue in Health, 2005
- Cholesterol‐lowering effects of rosuvastatin compared with atorvastatin in patients with type 2 diabetes – CORALL studyJournal of Internal Medicine, 2005
- Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III GuidelinesCirculation, 2004
- Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR**STELLAR = Statin Therapies for Elevated Lipid Levels compared Across doses to Rosuvastatin. Trial)The American Journal of Cardiology, 2003
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001